Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease [Phase 3]

View source ↗

Summary

This Phase 3 trial comparing risperidone to placebo for hallucinations and delusions in Alzheimer's disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Alzheimer's Disease, Dementia | Phase 3 | Status: TERMINATED